Avicenna Alliance Webinar: “Ensuring the Quality of In Silico Evidence for Medical Devices”
How can we ensure that in silico evidence is credible, reliable, and fit for regulatory decision-making?
When: 10 November 2026, 5PM CET
Where: Online
Enabling the Digital Revolution of Health
The society for in silico medicine
VPH is an international community driving the adoption of in silico medicine by connecting scientists, industry, clinicians, patients, healthcare providers, regulators, and policymakers for a better and more efficient healthcare.
-
25
Countries involved
-
40+
Institutions involved
-
1000+
Members
-
VPH2026 brings together 650 experts in Milan to advance in silico medicine
Read more
-
What is in silico medicine?
Discover more -
What is the VPH Society?
Discover more -
What do we do?
Discover more
Collaborations
-
-
-
-
News & Events
-
Discover more
-
VPH partners in two new EC projects: CHAIN and AIGENT
CHAIN and AIGENT kick off, strengthening European collaboration in artificial intelligence, digital twins and in silico medicine.
Discover more -
ARPA-H Launches SURPASS Program to accelerate Clinical Trials
The initiative aims to reduce clinical trial timelines to less than four years through artificial intelligence, predictive computational models and adaptive trial designs.
Discover more
